Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12943265 | 0.94 | ADORA1 (0.62) | ADORA1SLC6A3 | |
| SCHEMBL12907888 | 0.93 | ADORA1 (0.54) | ADORA1SLC6A3 | |
| SCHEMBL923720 | 0.91 | ADORA1 (0.65) | ADORA1SLC6A3 | |
| SCHEMBL923377 | 0.88 | ADORA1 (0.71) | ADORA1SLC6A3 | |
| SCHEMBL12907883 | 0.84 | ADORA1 (0.55) | ADORA1SLC6A3 | |
| SCHEMBL12907866 | 0.81 | ADORA1 (0.60) | ADORA1SLC6A3 | |
| SCHEMBL12943220 | 0.79 | ADORA1 (0.51) | ADORA1SLC6A3 | |
| SCHEMBL8007677 | 0.79 | ADORA1 (0.62) | ADORA1 | |
| SCHEMBL924848 | 0.77 | MAPK8 (0.39) | ADORA1 | |
| SCHEMBL3571933 | 0.77 | ADORA1 (0.65) | ADORA1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021487-A1 | CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND THEIR USE | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-01-27 | — | — | US | disclosed |
| WO-2009100827-A1 | CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021487-A1 | CYCLOALKOXY-SUBSTITUTED 4-PHENYL-3,5-DICYANOPYRIDINES AND THEIR USE | PC, DPP4, FABP3 | ADORA1 3492/4885SLC6A3 2324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.